Search Results - "Vargas, Maxemiliano V."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
  2. 2

    Psychedelics and Other Psychoplastogens for Treating Mental Illness by Vargas, Maxemiliano V, Meyer, Retsina, Avanes, Arabo A, Rus, Mark, Olson, David E

    Published in Frontiers in psychiatry (04-10-2021)
    “…Psychedelics have inspired new hope for treating brain disorders, as they seem to be unlike any treatments currently available. Not only do they produce…”
    Get full text
    Journal Article
  3. 3

    The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions by Shams, Shahin, Martinez, Joseph M, Dawson, John R D, Flores, Juan, Gabriel, Marina, Garcia, Gustavo, Guevara, Amanda, Murray, Kaitlin, Pacifici, Noah, Vargas, Maxemiliano V, Voelker, Taylor, Hell, Johannes W, Ashouri, Judith F

    Published in Frontiers in pharmacology (28-05-2021)
    “…Rheumatoid arthritis (RA) is a debilitating autoimmune disease with grave physical, emotional and socioeconomic consequences. Despite advances in targeted…”
    Get full text
    Journal Article
  4. 4

    Psychedelic-inspired drug discovery using an engineered biosensor by Dong, Chunyang, Ly, Calvin, Dunlap, Lee E., Vargas, Maxemiliano V., Sun, Junqing, Hwang, In-Wook, Azinfar, Arya, Oh, Won Chan, Wetsel, William C., Olson, David E., Tian, Lin

    Published in Cell (13-05-2021)
    “…Ligands can induce G protein-coupled receptors (GPCRs) to adopt a myriad of conformations, many of which play critical roles in determining the activation of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties by Atiq, Mazen A, Baker, Matthew R, Voort, Jennifer L Vande, Vargas, Maxemiliano V, Choi, Doo-Sup

    Published in Psychopharmacology (14-05-2024)
    “…Recent research with classic psychedelics suggests significant therapeutic potential, particularly for neuropsychiatric disorders. A mediating influence behind…”
    Get full text
    Journal Article
  7. 7

    5‑HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines by Cameron, Lindsay P., Patel, Seona D., Vargas, Maxemiliano V., Barragan, Eden V., Saeger, Hannah N., Warren, Hunter T., Chow, Winston L., Gray, John A., Olson, David E.

    Published in ACS chemical neuroscience (01-02-2023)
    “…Psychedelic compounds have displayed antidepressant potential in both humans and rodents. Despite their promise, psychedelics can induce undesired effects that…”
    Get full text
    Journal Article
  8. 8

    Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth by Ly, Calvin, Greb, Alexandra C, Vargas, Maxemiliano V, Duim, Whitney C, Grodzki, Ana Cristina G, Lein, Pamela J, Olson, David E

    Published in ACS pharmacology & translational science (09-04-2021)
    “…Cortical neuron atrophy is a hallmark of depression and includes neurite retraction, dendritic spine loss, and decreased synaptic density. Psychoplastogens,…”
    Get full text
    Journal Article
  9. 9

    Bryostatin 1 Promotes Synaptogenesis and Reduces Dendritic Spine Density in Cortical Cultures through a PKC-Dependent Mechanism by Ly, Calvin, Shimizu, Akira J, Vargas, Maxemiliano V, Duim, Whitney C, Wender, Paul A, Olson, David E

    Published in ACS chemical neuroscience (03-06-2020)
    “…The marine natural product bryostatin 1 has demonstrated procognitive and antidepressant effects in animals and has been entered into human clinical trials for…”
    Get full text
    Journal Article